Biora Therapeutics, Inc. PROG

As paperhands became desperate and capitulated, PROG will make the next move upward. These same paperhands will FOMO back in at that point.

Super low volume

@Luvmypup wants PROG to go below $2.50. Wahahaha. Let’s send this retail short some rockets today.

There are no shares left available to borrow. That’s why shorts can’t bring PROG below $2.50. Wahahaha.

No shares left to borrow for those sick retail shorts. Wahahaha. Get ready for the rockets.

As hard as shorts may try, shorts fail to bring PROG down below $2.50. PROG also didn’t go below $1 either. Chart looks bullish. Think. Don’t listen to FUDs

@Luvmypup is a retail short creating FUDs.

Progenity is currently partnering with Pfizer and Abbvie in studies to boost efficacy of FDA approved drugs. PROG is developing device and patents to boost drug efficacy. We are waiting for data from Phase 4 clinical trials this month. Previous data looks good in animal models. We expect the same for human trials.

@Luvmypup has short positions at $2.15. I know you wanted PROG to go below $2.50, $1, and zero. So I just bought another 70,000 shares. I want your house and your car dude. But you will also lose your wife when PROG goes to $10.

It will be so funny if PROG start ripping tomorrow when all hopes were given up

Fake News have now turned to writing professional hit jobs against retail stocks. We Only BUY and HODL.